CG Oncology, Inc.
CGON
$75.03
$0.320.43%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -31.32% | -45.74% | 5.70% | -5.75% | -20.24% |
| Total Depreciation and Amortization | 1.07% | -0.94% | 104.09% | 166.67% | 550.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 112.38% | -0.36% | 11.61% | 58.58% | -0.73% |
| Change in Net Operating Assets | 348.88% | -45.09% | -38.64% | -133.16% | 1,747.12% |
| Cash from Operations | 18.49% | -57.23% | 6.89% | -39.11% | 4.50% |
| Capital Expenditure | -53.95% | -4,242.86% | 92.78% | -592.86% | 12.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 100.00% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 109.24% | -343.11% | -303.45% | 2,511.47% | 100.76% |
| Cash from Investing | 109.09% | -343.47% | -601.86% | 969.30% | 100.75% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.47% | 296.77% | 83.19% | 284,636.84% | -97.21% |
| Repurchase of Common Stock | 88.51% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -195.74% | -20.51% | -114.44% | 185.71% | -35.78% |
| Cash from Financing | -99.51% | 296.70% | 82.21% | 18,468.24% | -165.78% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,262.31% | 109.56% | -141.46% | 213.68% | 87.55% |